| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3272668 | Journal de Gynécologie Obstétrique et Biologie de la Reproduction | 2013 | 7 Pages |
Abstract
Thrombotic risk among combined oral contraceptives (COC) users has recently been debated following a court action initiated by a patient. Recent epidemiological data, as well as accumulating biological data underlying these data, have led French Health authorities to modify COC prescription and reimbursement modalities. A short synthesis is proposed by a multidisciplinary group of experts from four French societies (CGOF, FNCGM, GHT, and SFMV)
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
N. Chabbert-Buffet, B. Guigues, N. Trillot, C. Biron, P. Morange, G. Pernod, M. Scheffler, S. Brugere, B. Hedon,